Insider Transactions in Q4 2023 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
4,272
-3.69%
|
$38,448
$9.24 P/Share
|
|
Dec 21
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,145
-1.29%
|
$9,160
$8.5 P/Share
|
|
Dec 21
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,920
-2.24%
|
$15,360
$8.5 P/Share
|
|
Dec 21
2023
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,400
-3.07%
|
$11,200
$8.5 P/Share
|
|
Dec 21
2023
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,860
-3.2%
|
$14,880
$8.5 P/Share
|
|
Dec 18
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
398
-0.46%
|
$3,184
$8.22 P/Share
|
|
Dec 18
2023
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
290
-0.63%
|
$2,320
$8.22 P/Share
|
|
Dec 18
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
238
-0.27%
|
$1,904
$8.22 P/Share
|
|
Dec 18
2023
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
386
-0.66%
|
$3,088
$8.22 P/Share
|
|
Dec 12
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,068
-1.19%
|
$7,476
$7.81 P/Share
|
|
Dec 12
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,926
-2.18%
|
$13,482
$7.81 P/Share
|